137 related articles for article (PubMed ID: 18232005)
1. Effectiveness of the ThinPrep Imaging System: clinical experience in a low risk screening population.
Papillo JL; St John TL; Leiman G
Diagn Cytopathol; 2008 Mar; 36(3):155-60. PubMed ID: 18232005
[TBL] [Abstract][Full Text] [Related]
2. Implementation of the ThinPrep Imaging System in a tertiary military medical center.
Duby JM; DiFurio MJ
Cancer; 2009 Aug; 117(4):264-70. PubMed ID: 19536887
[TBL] [Abstract][Full Text] [Related]
3. The significance of "low-grade squamous intraepithelial lesion, cannot exclude high-grade squamous intraepithelial lesion" as a distinct squamous abnormality category in Papanicolaou tests.
Elsheikh TM; Kirkpatrick JL; Wu HH
Cancer; 2006 Oct; 108(5):277-81. PubMed ID: 16937376
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the clinical significance of the Papanicolaou test interpretations LSIL cannot rule out HSIL and ASC-H.
Difurio MJ; Mailhiot T; Sundborg MJ; Nauschuetz KK
Diagn Cytopathol; 2010 May; 38(5):313-7. PubMed ID: 19813258
[TBL] [Abstract][Full Text] [Related]
5. Atypical squamous cells, cannot exclude high-grade squamous intraepithelial lesion: diagnostic performance, human papillomavirus testing, and follow-up results.
Srodon M; Parry Dilworth H; Ronnett BM
Cancer; 2006 Feb; 108(1):32-8. PubMed ID: 16136595
[TBL] [Abstract][Full Text] [Related]
6. Distribution of human papillomavirus types in ThinPrep Papanicolaou tests classified according to the Bethesda 2001 terminology and correlations with patient age and biopsy outcomes.
Evans MF; Adamson CS; Papillo JL; St John TL; Leiman G; Cooper K
Cancer; 2006 Mar; 106(5):1054-64. PubMed ID: 16421920
[TBL] [Abstract][Full Text] [Related]
7. Performance of an imaging system vs. manual screening in the detection of squamous intraepithelial lesions of the uterine cervix.
Dziura B; Quinn S; Richard K
Acta Cytol; 2006; 50(3):309-11. PubMed ID: 16780026
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of the ThinPrep Imaging System in the detection of abnormal cervicovaginal cytology: a practical experience in Korea.
Ha SY; Lee YK; Oh YL
Acta Cytol; 2013; 57(2):159-63. PubMed ID: 23406895
[TBL] [Abstract][Full Text] [Related]
9. Performance of HPV DNA testing with hybrid capture 2 in triaging women with minor cervical cytologic abnormalities (ASC-US/LSIL) in Northern Thailand.
Khunamornpong S; Settakorn J; Sukpan K; Srisomboon J; Suprasert P; Siriaunkgul S
Asian Pac J Cancer Prev; 2014; 15(24):10961-6. PubMed ID: 25605209
[TBL] [Abstract][Full Text] [Related]
10. Significance of high-risk human papillomavirus DNA detection in women 50 years and older with squamous cell papanicolaou test abnormalities.
Zhao C; Zhao S; Heider A; Austin RM
Arch Pathol Lab Med; 2010 Aug; 134(8):1130-5. PubMed ID: 20670132
[TBL] [Abstract][Full Text] [Related]
11. Low-grade pap smears containing occasional high-grade cells as a predictor of high-grade dysplasia.
Power P; Gregoire J; Duggan M; Nation J
J Obstet Gynaecol Can; 2006 Oct; 28(10):884-887. PubMed ID: 17140504
[TBL] [Abstract][Full Text] [Related]
12. Off-label high-risk HPV DNA testing of vaginal ASC-US and LSIL cytologic abnormalities at Parkland hospital.
Chappell CA; West AM; Kabbani W; Werner CL
J Low Genit Tract Dis; 2010 Oct; 14(4):352-5. PubMed ID: 20885164
[TBL] [Abstract][Full Text] [Related]
13. Liquid-based cytology--new possibilities in the diagnosis of cervical lesions.
Juric D; Mahovlić V; Rajhvajn S; Ovanin-Rakić A; Skopljanac-Macina L; Barisić A; Projić IS; Babić D; Susa M; Corusić A; Oresković S
Coll Antropol; 2010 Mar; 34(1):19-24. PubMed ID: 20432728
[TBL] [Abstract][Full Text] [Related]
14. [HPV E6 and E7 mRNA combined with HPV 16 and 18 or 45 genotyping testing as a means of cervical cancer opportunistic screening].
Wang JJ; Dong J; Deng ZX; Wang PF; Zhang XX; Du Y
Zhonghua Fu Chan Ke Za Zhi; 2019 May; 54(5):301-306. PubMed ID: 31154710
[No Abstract] [Full Text] [Related]
15. Role of p16(INK4a) cytology testing as an adjunct to enhance the diagnostic specificity and accuracy in human papillomavirus-positive women within an organized cervical cancer screening program.
Gustinucci D; Passamonti B; Cesarini E; Butera D; Palmieri EA; Bulletti S; Carlani A; Staiano M; D'Amico MR; D'Angelo V; Di Dato E; Martinelli N; Malaspina M; Spita N; Tintori B; Fulciniti F
Acta Cytol; 2012; 56(5):506-14. PubMed ID: 23075891
[TBL] [Abstract][Full Text] [Related]
16. LSIL/ASC-H (LSIL-H) in cervicovaginal smear: histopathological outcomes and clinical significance.
Kaygusuz EI; Cetiner H; Sahin D
Turk Patoloji Derg; 2011 Jan; 27(1):46-50. PubMed ID: 21469426
[TBL] [Abstract][Full Text] [Related]
17. Low-grade squamous intraepithelial lesion/cannot exclude high-grade squamous intraepithelial lesion (LSIL-H) is a unique category of cytologic abnormality associated with distinctive HPV and histopathologic CIN 2+ detection rates.
Barron S; Li Z; Austin RM; Zhao C
Am J Clin Pathol; 2014 Feb; 141(2):239-46. PubMed ID: 24436272
[TBL] [Abstract][Full Text] [Related]
18. Should women with atypical squamous cells, cannot exclude high-grade squamous intraepithelial lesion, receive reflex human papillomavirus-DNA testing?
Liman AK; Giampoli EJ; Bonfiglio TA
Cancer; 2005 Dec; 105(6):457-60. PubMed ID: 16104044
[TBL] [Abstract][Full Text] [Related]
19. Comparative analysis of a liquid-based Pap test and concurrent HPV DNA assay of residual samples. A study of 608 cases.
Hong IS; Marshalleck J; Williams RH; Gaiter TE; Mielzynska-Lohnas I; Kim K
Acta Cytol; 2002; 46(5):828-34. PubMed ID: 12365215
[TBL] [Abstract][Full Text] [Related]
20. Cytology and outcome of LSIL: cannot exclude HSIL compared to ASC-H.
Hunter C; Duggan MA; Duan Q; Power P; Gregoire J; Nation J
Cytopathology; 2009 Feb; 20(1):17-26. PubMed ID: 18510551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
